Blood was collected from mice in 1 mL syringes containing 0.5 mM EDTA ... Flow cytometry data were acquired using BD FACSCanto II (BD Biosciences) and analyzed using FlowJo software. Cell sorting was ...

Here we report the discovery and development of a potent small molecule inhibitor of TNF that was recently moved into phase 1 clinical ... of 4 ng/ml (Room temperature, 60 min). Cells were plated into ...

BD has increased its manufacturing capacity for critical medical supplies, including syringes, needles and IV ... shut down a facility in Ireland over 2 1/2 years, potentially resulting in the ...

The global oral syringes market size is estimated to reach USD 1.05 billion by 2030, registering a CAGR of 6.1% from 2025 to 2030. The factors driving market growth are the growing prevalence of ...

Avery Dennison, in partnership with Turck Vilant Systems & Becton, Dickinson and Company, introduces BD iDFill Individual ...

BD (NYSE: BDX) announced today that it plans to invest further in U.S. manufacturing to add capacity for certain critical medical devices.

BD invested $10 million last year to increase manufacturing capacity. The recent expansion has created more than 200 jobs.

BD (NYSE: BDX) + plans to close a facility in ... safety-engineered injection devices by more than 40%, with conventional syringes increasing by more than 50%. The company said increased capacity ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...